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Serine repeat antigens (SERAs) are a family of secreted “cysteine-like” proteases of Plasmodium
parasites. Several SERAs possess an atypical active-site serine residue in place of the canonical cysteine.
The human malaria parasite Plasmodium falciparum possesses six “serine-type” (SERA1 to SERA5 and
SERA9) and three “cysteine-type” (SERA6 to SERA8) SERAs. Here, we investigate the importance of the
serine-type SERAs to blood-stage parasite development and examine the extent of functional redundancy
among this group. We attempted to knock out the four P. falciparum serine-type SERA genes that have not
been disrupted previously. SERA1, SERA4, and SERA9 knockout lines were generated, while only SERA5,
the most strongly expressed member of the SERA family, remained refractory to genetic deletion. Inter-
estingly, we discovered that while SERA4-null parasites completed the blood-stage cycle normally, they
exhibited a twofold increase in the level of SERA5 mRNA. The inability to disrupt SERA5 and the apparent
compensatory increase in SERA5 expression in response to the deletion of SERA4 provides evidence for an
important blood-stage function for the serine-type SERAs and supports the notion of functional redun-
dancy among this group. Such redundancy is consistent with our phylogenetic analysis, which reveals a
monophyletic grouping of the serine-type SERAs across the genus Plasmodium and a predominance of
postspeciation expansion. While SERA5 is to some extent further validated as a target for vaccine and
drug development, our data suggest that the expression level of other serine-type SERAs is the only barrier
to escape from anti-SERA5-specific interventions.
New drugs and a vaccine are urgently needed to facilitate
effective and sustained control of the protozoan parasite Plas-
modium falciparum, the most significant cause of malaria.
Novel enzymes that are both accessible and essential to para-
site development in the blood are attractive therapeutic tar-
gets. Proteases that function in the erythrocytic cycle are prom-
ising in this regard, as many of them appear to have unique
properties and/or function in parasite-specific processes such
as hemoglobin digestion and parasite invasion of host erythro-
cytes (5, 21, 25, 29).
Accordingly, the P. falciparum serine repeat antigens (SERAs)
also have potential as drug targets. These proteins are ex-
pressed in the parasitophorous vacuole of mature, erythro-
cytic-stage parasites (8, 13, 20), and all of them possess a
papain protease-like central domain flanked by two novel and
relatively cysteine-rich domains. Several SERA proteins,
termed the “serine-type” SERAs, possess an atypical serine
residue in the active-site position of the enzyme domain usu-
ally occupied by a canonical cysteine. The enzyme domain
from at least one serine-type SERA, SERA5, retains a degree
of catalytic function; however, it is uncertain if this proteolytic
activity has biological relevance (12). The P. falciparum ge-
nome contains a total of nine SERA genes, six of which encode
serine-type SERA proteins and three of which encode more
classical cysteine-type SERAs (2, 11, 20). These two types of
SERA proteins form distinct phylogenetic groups not just
within P. falciparum but also across the Plasmodium genus,
suggesting different biological roles for members of each type
(3, 12). The precise nature and relevance of these roles remain
to be determined.
While it has been established that all members of the P.
falciparum SERA gene family, eight of which are tandemly
arrayed genes on chromosome 2 (SERA1 to SERA8), and a
ninth gene on chromosome 9 (SERA9), are expressed in a
coregulated manner late in the blood-stage cycle, it is clear that
each member is expressed at very different levels (2, 4, 18–20).
This expression pattern is similar across all parasite lines ex-
amined to date, and multiple SERAs are expressed in the one
parasite, suggesting that family members are not differentially
expressed. Proteomic data, although not strictly quantitative,
suggest a strong concordance between mRNA and protein
levels, with SERA5 peptides detected with extraordinary fre-
quency (16). SERA5 ranked fourth (159 peptides) in a list of
712 trophozoite/schizont proteins detected. SERA4 peptides
were also well represented in this analysis, ranking 79th (22
peptides), together with SERA6 (208th; nine peptides),
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SERA3 (209th; nine peptides), SERA7 (380th; three pep-
tides), and SERA9 (457th; two peptides). A separate pro-
teomic analysis of P. falciparum schizonts yielded almost iden-
tical results (17). It is important that some SERA family
members that are expressed weakly in the erythrocytic cycle
may be predominantly expressed at other stages.
Several lines of evidence suggest that a possible role for
some members of this family is to promote merozoite egress
from infected erythrocytes. Apart from their appropriate loca-
tion in the parasitophorous vacuole, it has been shown that
antibodies specific for SERA5 appear to impede schizont rup-
ture (23). Related to this, the targeted deletion of a P. falcip-
arum cysteine-type SERA homologue (SERA8) in P. berghei,
which is predominantly expressed in sporozoites, results in the
arrest of sporozoite egress from oocysts in the mosquito (1).
While it is attractive to contemplate a generic role in parasite
egress for this family of proteins at different life stages, it
remains to be demonstrated if this is the case. Moreover, the
reason for so many SERA genes, and for a variable number
between species (3), remains a mystery.
In order to probe the biological role of the SERAs during
the blood stage, we previously attempted to disrupt each of the
SERA genes clustered on chromosome 2 using a single-cross-
over recombination approach (7). Using this technology, we
disrupted the peripherally located genes (SERA2, SERA3,
SERA7, and SERA8) but were unsuccessful in targeting the
peripherally located gene SERA1 or any of the more strongly
expressed genes, SERA4, SERA5, and SERA6 (20). Since then,
another more powerful gene-targeting technology has been
developed for P. falciparum. This approach involves selecting
double-crossover integrants using a combination of both pos-
itive and negative selectable markers (9). In this study, we used
this method as well as repeating the single-crossover approach
in an attempt to disrupt the two most strongly expressed mem-
bers of the SERA family, SERA4 and SERA5, and the remain-
ing two serine-type SERAs, SERA1 and SERA9. While the
SERA5 gene remained refractory to deletion, we were able to
disrupt SERA1, SERA4, and SERA9. SERA4-null parasites
displayed a twofold increase in the expression of SERA5
mRNA. We also performed a comprehensive analysis of ge-
nome sequences of Plasmodium species parasites and demon-
strate that, in contrast to the cysteine-type members, the
serine-type SERAs form a monophyletic group that have ex-
panded postspeciation. Together, these data provide evidence
for a key, probably single, role for serine-type SERAs in the
erythrocytic cycle.
MATERIALS AND METHODS
Plasmid design and construction. DNA was amplified via PCR from a mixed
trophozoite/schizont parasite genomic DNA (gDNA) template. Preparation of
genomic DNA was performed as described previously (28). Each reaction mix-
ture contained 200 M deoxynucleoside triphosphate, 200 nM each primer, 0.5
units of Platinum Taq DNA polymerase high-fidelity enzyme (Gibco BRL), 2.0
mM MgSO4, and 200 ng template. The double-crossover transfection vectors
contain 5- and 3-targeting sequences for homologous recombination into the
genome. These sequences were obtained by amplifying SERA sequences from P.
falciparum gDNA using the oligonucleotides specified in Tables S1 and S2 in the
supplemental material. The resulting fragments were cloned into the SacII/BglII
(5 target) and AvrII/EcoRI or AvrII/ClaI (3 target) sites of pHTK (9). Ligation
of PCR products into the appropriate plasmid was performed as previously
described (26), with the exception that polyethylene glycol 8000 (1%) and ATP
(1 mM) were added to each ligation reaction mixture. The ligated DNA was
electroporated into Escherichia coli strain PMC103 using the Bio-Rad Gene
Pulser II electroporation system and the Pulse Controller unit.
Parasite culture and transfection. P. falciparum asexual erythrocytic-stage
parasites (D10 or 3D7 lines) were cultivated at 37°C, 5% CO2, 1% N2, and 1%
O2 (27) in 4% hematocrit using human O-positive erythrocytes and fed every
second day with complete culture medium (RPMI-HEPES supplemented with
0.2% NaHCO3, 5% heat inactivated human serum, and 5% Albumax). Enriched
trophozoite and schizont preparations used in Western blot analyses were ob-
tained by Percoll purification (29). Ring-stage parasites (5% parasitemia) were
transfected with 100 g of purified plasmid DNA (plasmid maxi kit; Qiagen) (6)
using modified electroporation conditions (10), and drug cycling commenced
according to methods described previously by Crabb et al. and Duraisingh et al.
(7, 9). Briefly, parasites were cultured in a 10-cm culture dish for 48 h prior to
selection with 2.5 nM WR99210. Transfected parasites were visible after 3 weeks
of continuous culture. Parasites containing integrated forms of the plasmid were
obtained by drug cycling, where drug was removed for 2 to 3 weeks before being
reapplied.
Southern blotting. Total parasite DNA was isolated from saponin (0.15%)-
lysed trophozoite- and schizont-infected erythrocytes at 5% parasitemia. Buffer
A (50 mM NaAc [pH 5.2], 100 mM NaCl, 1 mM EDTA) and sodium dodecyl
sulfate (SDS) (3% [wt/vol]) were added to the saponin-lysed pellet and mixed by
inversion. The resultant mixture was extracted using phenol-chloroform (1:1)
(Progen). The aqueous phase was ethanol precipitated as described previously
(26), and the DNA pellets were air dried and resuspended in 500 l of Tris-
EDTA. Manipulation of recombinant DNA and analysis of nucleic acids by
Southern blot hybridization were carried out using standard procedures (26).
SDS-polyacrylamide gel electrophoresis and Western blotting. Parasite pro-
teins extracted from trophozoite and schizont preparations that had been puri-
fied by Percoll density gradient (64%) were separated by SDS-polyacrylamide gel
electrophoresis (15) on 4 to 20% polyacrylamide gradient Tris–HEPES–sodium
dodecyl sulfate-polyacrylamide gel electrophoresis gels under reducing condi-
tions and transferred onto polyvinylidene difluoride membranes (Amersham)
using the Bio-Rad Mini-Protean II electrophoresis cell and a Mini Tran-Blot
electrophoretic transfer cell apparatus according to the manufacturer’s instruc-
tions. After transfer, polyvinylidene difluoride membranes were blocked in 5%
(wt/vol) skim milk in phosphate-buffered saline overnight at 4°C. Membranes
were probed with rabbit anti-SERA-specific polyclonal antibodies. The antibod-
ies and methodology used were described in a previous study (20). Horseradish
peroxidase-conjugated sheep anti-rabbit or sheep anti-human immunoglobulin
G (Silenus Laboratories) diluted 1/3,000 was used for detection.
Growth rate assay. Ring-stage wild-type and knockout parasites were synchro-
nized by sorbitol lysis twice at 4-h intervals and plated in duplicate at 0.5%
parasitemia into complete culture medium containing a 4% hematocrit in the
absence of drug selection. Methanol-fixed and Giemsa-stained thin blood smears
were made every 48 h for a total of 28 days. Fresh medium was added every 48 h,
and cultures were maintained below a parasitemia of 5%.
Microarray. Microarrays comprised of 6,912 P. falciparum 70-mer oligonucle-
otides were printed in duplicate on polylysine-coated microscope slides (Operon
Technologies) as described previously (4). Highly synchronous P. falciparum D10
parasite cultures were obtained by double-sorbitol treatment (5%; Sigma) and
used to measure SERA gene expression levels between mature (trophozoite/
schizont) and young (ring) D10 parasites. For this, parasitized erythrocytes were
lysed by saponin lysis (0.15%), and the RNA was extracted using RNeasy Mini-
columns (Qiagen). Total RNA (20 g) was reverse transcribed overnight using
SuperScript II (Gibco BRL). The reactive amino group of aa-dUTP was used to
conjugate 2 g of the purified cDNA preparations with 100 g of the fluorescent
dye esters N-hydroxysuccinimide–Cy3 (Amersham) and N-hydroxysuccinimide–
Cy5 (Amersham). Microarrays were hybridized overnight at 42°C with 500 ng of
each fluorescently labeled probe in a solution containing 25% (vol/vol) formam-
ide, 5 SSC (1 SSC is 0.15 M NaCl plus 0.015 M sodium citrate), and 0.1%
(wt/vol) SDS. Arrays were washed twice at room temperature with 1 SSC–0.2%
SDS, followed by two stringent washes (0.1 SSC) prior to scanning on a
ScanArray 4000 apparatus (GSI Lumonics). Data were extracted from the raw
images and mined using GeneSpring (Silicon Genetics).
Quantitative reverse transcription (RT)-PCR. Parasitized erythrocytes at 36 to
40 h postsynchronization were lysed by saponin lysis, and RNA was extracted
using RNeasy Minicolumns (Qiagen). Total RNA (5 g) was reverse transcribed
using SuperScript II (Gibco BRL), and 500 ng of the resultant cDNA was added
to the QuantiTect SYBR green PCR mixture (Qiagen) containing the gene-
specific oligonucleotides specified in Table S1 in the supplemental material. PCR
was performed using a LightCycler apparatus (Roche), and reaction conditions
were as follows: 95°C (15 min), followed by 40 cycles of 95°C (15 s), 45°C (30 s),
and 67°C (20 s). Serial dilutions of P. falciparum D10 genomic DNA were used
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as a standard reference control. The same preparation procedure was followed
when performing quantitative PCR on parasite preparations isolated following a
time course for wild-type D10 and D10-SERA4 parasite lines. Parasites in each
line were collected at 30 h postsynchronization and subsequent 4-h intervals for
20 h and prepared as described above.
Database searches and phylogenetic analysis. HMMER (http://hmmer.janelia
.org) profiles were generated for the conserved protease and C-terminal domains
of aligned P. falciparum 3D7 SERA proteins. These profiles were used to search
a database of six-frame translations of genomic sequences as well as protein
sequences of apicomplexan species. From the results, matches were extracted for
the following species: P. falciparum (three strains), Plasmodium reichenowi, Plas-
modium vivax, Plasmodium knowlesi, Plasmodium yoelii, Plasmodium berghei,
Plasmodium chabaudi, Plasmodium gallinaceum, and Theileria annulata. In the
case of T. annulata, only the protease domain was matched by the hidden Markov
model (HMM) profiles generated. Alignment of the corresponding T. annulata
protein sequence with P. falciparum cysteine-type SERA sequences indicated the
presence of a divergent (and therefore unrecognized by the C-terminal HMM
profile) but homologous C-terminal domain in which all seven cysteine residues
were conserved. The C-terminal portion of the T. annulata sequence was ex-
tracted from the multiple alignment and used for further analyses.
A multiple alignment was constructed from concatenated protease and C-
terminal domains using Hmmalign. This alignment consisted of 354 characters
over 71 sequences. P. reichenowi SERA8 was removed because the obtained
sequence was partial. For cysteine-type SERAs lacking a C-terminal domain
(e.g., P. falciparum SERA8, P. yoelii SERA5, and P. vivax SERA12), gaps were
inserted to pad the alignment. Phylogenetic analyses were carried out using
MrBayes (24) with fixed Blosum62 transition probabilities and substitution rates
of (4)  I. In parallel, topologies were inferred using neighbor-joining and
maximum likelihood methods as implemented by Phylip (Phylogeny Inference
Package version 3.6; J. Felsenstein, Department of Genome Sciences, University
of Washington, Seattle). Internal branch splits congruent between Markov chain
Monte Carlo (MCMC), maximum likelihood, and neighbor-joining methods
were recorded. In order to examine support for the Cys-Ser split in the inferred
phylogeny, we removed all trees from the MCMC sampling that contained this
branch partition and reanalyzed the remainder of the data.
RESULTS
SERA5 is the only serine-type SERA gene that is refractory
to genetic deletion. Two of the six serine-type SERA genes,
SERA2 and SERA3, have previously been disrupted in P. fal-
ciparum blood stages using a single-crossover approach; how-
ever, this same methodology was not successful in deleting
three other genes in this class, SERA1, SERA4, and SERA5
(20). The sixth member of this group, SERA9, has not been
targeted previously. Here, we attempted to disrupt the genes
encoding four serine-type SERA genes, SERA1, SERA4,
SERA5, and SERA9, for which knockout lines had not previ-
ously been generated. We employed the single-crossover re-
combination approach to target SERA1 because although this
approach was unsuccessful in our previous study (20), unlike
the other genes in our previous work, it was not repeated on
multiple occasions. A double-crossover recombination ap-
proach was used for SERA4, SERA5, and SERA9 (Fig. 1). For
these genes, 5 (FL1) and 3 (FL2) regions of the target genes
were cloned into the transfection plasmid pHTK to facilitate
gene targeting (9). Each plasmid was transfected into D10
and/or 3D7 parasite lines, and stable parasite populations were
obtained using the positive selection agent WR99210. Negative
selection was then applied by culturing the parasite popula-
tions in the presence of ganciclovir. In some cases, populations
were routinely subjected to drug cycling on and off with
WR99210 and ganciclovir (cycle 1 [C1] and C2, etc.) to facil-
itate selection for integrant lines.
In order to test whether the transfected plasmids had inte-
grated into the correct locus, Southern blot analysis was used
to probe restriction-digested genomic DNA from both paren-
tal parasites and one of the selected parasite clones. Filters
were probed with either the 5 or 3 DNA fragments repre-
senting the unique targeting sequence in each plasmid (Fig. 1).
Restriction enzymes were chosen to reveal a distinct size dif-
ference in fragments representing the wild-type locus, the in-
tegrated locus, and the episomal plasmid when the blots were
hybridized to a targeting sequence probe.
In the case of SERA1, Southern blot analysis identified a
band of 4.6 kb corresponding to the endogenous SERA1 locus
in wild-type 3D7. The disappearance of this fragment together
with the appearance of fragments representing the targeted
locus confirms successful single-crossover homologous recom-
bination (Fig. 1). It should be noted that plasmids that inte-
grate by single-crossover recombination often insert more than
one copy into the locus, and if this has occurred, a band
corresponding to that expected for the episomal plasmid would
be observed. This was the case for SERA1, where, based on
band intensity, one additional copy was inserted (Fig. 1).
With respect to the targeting of the SERA4 gene, hybridiza-
tion with the FL1 and FL2 targeting sequences of SERA4
identified single bands of 5.4 kb and 1.8 kb in D10 corre-
sponding to the endogenous gene. In the transfected D10-
SERA4/C0 line, which had not undergone ganciclovir selec-
tion, the bands at 2.6 kb and 4.0 kb indicated the presence of
plasmid pTKSERA4. However, in D10-SERA4 parasites,
which had undergone negative selection pressure, single bands
at 6.0 kb and 2.5 kb indicated that the plasmid had integrated
into the SERA4 gene via the expected double-crossover event
(Fig. 1). Therefore, although we were previously unable to
disrupt SERA4 using single-crossover technology, a SERA4
“knockout” was obtained by using the negative selection pro-
cedure.
In an attempt to delete SERA5, plasmid pHTKSERA5 was
transfected into D10 parasites on four separate occasions, and
parasites were cycled as described above. Parasites were ana-
lyzed by pulsed-field gel electrophoresis, and in all rounds of
drug cycling hybridizations of both the hDHFR probe and the
pGEM probe to D10-pHTKSERA5, either parasites pro-
duced a smeared multiple banding pattern consistent with
episomal maintenance of the plasmid or the hDHFR probe
appeared to hybridize to a chromosome other than chromo-
some 2, suggesting that the plasmid integrated elsewhere into
the genome, possibly by nonhomologous recombination (data
not shown). Southern blot analysis revealed that all attempts to
integrate the plasmid into the genome were unsuccessful (Fig.
1). Hence, our attempts to disrupt SERA5 in the D10 line
made in this study, together with the multiple attempts in both
D10 and 3D7 lines described in our previous study (21), sug-
gest an important role for this protein in the erythrocytic cycle.
SERA9, which is located on chromosome 9 and is the only
SERA gene not contained in the chromosome 2 locus, has not
been previously targeted for deletion. Plasmid pHTKSERA9
was transfected into D10 parasites and cycled in the same way
as described above. Hybridization with the targeting sequence
of SERA9 identified a single band of 2.0 kb in D10 corre-
sponding to the endogenous gene. In the transfected D10-
SERA9/C0 line that had not undergone negative selection, the
bands at 2.0 kb and 9.6 kb indicate the presence of plasmid
pTKSERA9. However, in the D10-SERA9 parasites, which
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had undergone negative selection pressure with ganciclovir, a
single band at 5.4 kb indicated that the plasmid had integrated
into the SERA9 gene via the expected event (Fig. 1).
In summary, we have successfully disrupted SERA1, SERA4,
and SERA9, while SERA5 remained refractory to deletion. As
we previously deleted SERA2 and SERA3, it is apparent that
five of the six members of the serine-type SERA family are not
essential to in vitro blood-stage growth, while SERA5 appears
to be important for the maintenance of this life cycle stage.
Deletion of SERA4 leads to a transcriptional up-regulation
of SERA5. The phenotype of SERA4 knockout parasites was
analyzed in detail, considering that it is the second-highest-
expressing member of the SERA family (after SERA5) in the
erythrocytic cycle (2, 20). Late-stage parental D10 and D10-
SERA4 parasite proteins were separated on a 10% poly-
acrylamide gel and subjected to Western blot analysis to con-
firm that the disruption of the SERA4 gene had specifically
affected production of the SERA4 protein (Fig. 2A). Duplicate
membranes were probed with either rabbit anti-SERA4 poly-
clonal antibodies or rabbit anti-Hsp70 polyclonal antibodies as
a protein loading control. Full-length SERA4 was detected at
approximately 100 kDa in D10 and D10-SERA4/C0 para-
sites, a line containing an episomal form of the plasmid, but
not in the two cloned D10-SERA4 lines. Integration of plas-
mid pHTKSERA4 into the SERA4 gene was expected to
result in a truncated SERA4 gene predicted to encode the first
157 amino acids of the 963-amino-acid wild-type SERA4 pro-
tein. A truncated form of SERA4 was not detected by Western
blot analysis of D10-SERA4 parasites (data not shown).
Western blot analysis was used to determine if the expres-
sion profile of other SERA proteins had changed in the para-
site line lacking the SERA4 protein. Rabbit antibodies specific
FIG. 1. Targeted disruption of four serine-type SERA genes. (A) Schematic representation detailing the outcome of expected integration events
in SERA knockout parasite lines. Solid lines under the exons represent the location of the gene targeting regions used to clone fragments into
pHH1 (SERA1), pTKSERA4, pTKSERA5, and pTKSERA9. The targeting regions of the coding sequence are indicated by the gray shaded
regions. (B) Southern blots summarizing the result of the attempted targeted disruption of each SERA gene using restriction-digested genomic
DNA from each transfected line following drug cycling and parental parasites. Genomic DNA was digested BstBI (B)/SphI (S) for SERA1, AflIII
(A) for SERA4, XmnI (X) for SERA5, and BclI (Bc)/NotI/SwaI (Sw) for SERA9. The membranes were probed with each respective targeting
sequence shown above (A). The positions of endogenous (E), plasmid (P), and integration-specific fragment (In) events that result from digestion
with the respective enzymes and the probing of blots with the specific targeting region (gray) are indicated, and their molecular weights (in
thousands) are given below each relevant blot. RE, restriction enzyme.
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for recombinant forms of each of the nine SERA proteins were
tested for reactivity with D10 (Fig. 2B) and D10-SERA4 (Fig.
2C) parasite proteins extracted from late-stage parasites. Anti-
SERA4, anti-SERA5, and anti-SERA6 antibodies reacted
strongly with the expected species in the parental D10 extracts.
However, as expected, only SERA5 and SERA6 were detected
in the D10-SERA4 knockout line. SERA proteins 1, 2, 3, 7,
8, and 9 were not obvious in either D10 or D10-SERA4
parasites, suggesting that they remain at low levels of expres-
sion in both circumstances.
In vitro growth of the D10 parental line was compared with
the D10-SERA4 parasite line to determine whether the de-
letion of SERA4 had any deleterious effect on the ability of
these parasites to propagate in blood-stage cultures (Fig. 3).
Parasites were synchronized at ring stages, and growth and
stage distribution were followed thereafter over a 28-day time
period by examination of thin blood smears every 2 days. No
detectable difference in growth rates was observed between the
parental line and the mutant parasites at any stage over this
period.
In order to investigate whether any members of the SERA
multigene family were affected at a transcriptional level in
response to the disruption of the SERA4 gene, schizont-stage
transcripts were analyzed in both the parental D10 line and the
D10-SERA4 line using a combination of microarray and
quantitative PCR analyses. Competitive microarray analysis
was performed on two occasions using 6,912 70-mer oligonu-
cleotides printed in duplicate on polylysine-coated microscope
slides (as described in reference 4). Interestingly, in both ar-
rays, SERA5 was up-regulated by approximately threefold in
the D10-SERA4 knockout line in comparison to the parental
D10 line (see Fig. S1 in the supplemental material). This was
the only gene that showed consistent and obvious transcrip-
tional changes using this method. In addition to this, the co-
regulated schizont-stage control genes MSP-2, MSP-4, and
MSP-5 remained unchanged in the D10-SERA4 parasite line.
To independently confirm an up-regulation of SERA5
mRNA in SERA4 knockout parasites, we used quantitative
RT-PCR. To account for any differences in the synchrony of
the parasite lines, we tested RNA extracted from parasites
isolated from time courses at 4-h intervals. Expression levels
were normalized to the expression of MSP-1, a gene that has a
very similar transcriptional profile (Fig. 4). As expected, the
level of SERA4 mRNA transcripts was dramatically reduced in
the D10-SERA4 parasite line. We consistently observed a
twofold increase in SERA5 transcript in SERA4 knockout par-
asites, while mRNA levels of other SERA genes did not
change. These data suggest that a compensatory up-regulation
of SERA5 is required in the absence of SERA4. As mRNA and
protein levels of SERA appear to be roughly concordant, we
expect that such a transcriptional change leads to increased
SERA5 protein in SERA4 knockout parasites. However, any
change in protein levels was not sufficiently large to be de-
tected by semiquantitative Western blotting (data not shown).
Analysis of complete apicomplexan genome sequences dem-
onstrates that serine-type SERAs form a single monophyletic
group. Although all known SERAs are relatively closely re-
lated, previous phylogenetic analyses of this family suggested
that serine-type and cysteine-type SERAs form separate phy-
FIG. 2. Western blot analysis of SERA4-null parasites. (A) West-
ern blots of total material from synchronized late-blood-stage parasites
comparing the parental D10 wild type with two clones of D10-SERA4
were probed with either rabbit anti-Hsp70 polyclonal or rabbit anti-
SERA4 polyclonal antibody. The antisera used to probe each mem-
brane are indicated at the bottom of the gel. Molecular mass markers
(kDa) are shown to the left of the membrane. (B and C) Western blots
of total material from synchronized late-blood-stage parasites from
wild-type D10 (B) or D10-SERA4 (clone 1) (C) probed with rabbit
anti-SERA1 to anti-SERA9 polyclonal antibodies specific to the N-
terminal region of each SERA protein (lanes 1 to 9, respectively). The
antiserum used to probe each membrane strip is indicated at the top of
the lane. The strip probed with the prebleed pool is indicated by P.
Molecular mass markers (kDa) are shown to the left of each mem-
brane.
FIG. 3. Disruption of SERA4 does not affect in vitro parasite
growth. Shown are data from an extended growth rate assay comparing
D10 wild-type parasites with the D10-SERA4 (D10-S4) parasite
line over a 28-day period. Parasites were maintained below 5%. Error
bars represent the standard deviations of mean parasitemias from
three individual counts.
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logenetic groups indicative of an ancient split between these
types and the subsequent species-specific expansion of the
serine-type SERAs (3, 12, 14). An ancient split and monophy-
letic grouping support a conserved function for the serine-type
SERAs. However, those previous studies involved only a few
Plasmodium species and the use of mostly incomplete ge-
nomes. In one study, this led to a prediction of “missing” genes
that would be identified upon further sequencing (3). Since
that time, there has been a vast increase in sequence data
available for a wide array of Plasmodium species and other
apicomplexan parasites. Here, we reexamine the phylogeny of
the SERA genes utilizing complete genome sequence data in
order to ascertain if the original premise holds.
Beginning with HMM profiles generated from P. falciparum
SERA sequences, we sought to locate and extract conserved
domains of SERA genes from the genomes of sequenced api-
complexan species. By using this approach and by restricting
ourselves to species for which whole-genome sequencing has
been undertaken, we aimed to generate a map of SERA loci in
the surveyed genomes that was as complete as possible. This
map of the genomic arrangement (Fig. 5) together with the
phylogeny (Fig. 6) constructed from the retrieved sequences
shed light on the evolution of the SERA family and lend
support to the hypothesis of a single function for serine-type
SERAs.
To date, orthologs of P. falciparum SERA genes have been
discovered only in other species of Plasmodium. Sequence
similarity searches indicate that the SERA family is specific to
this genus, and entries for SERA genes in orthology databases
such as OrthoMCL reflect this. Using the profiles generated,
however, we discovered a putative SERA ortholog in Theileria
annulata. This is the first time that an ortholog has been iden-
tified outside plasmodia. The features and the genomic loca-
tion of the T. annulata SERA both suggest that the SERA locus
in the common ancestor of Plasmodium and Theileria species
consisted of a single sequence orthologous to P. falciparum
FIG. 4. Higher levels of SERA5 mRNA are present in SERA4-null parasites. (A and B) SERA gene transcript expression levels in late-blood-
stage D10 wild-type (A) andD10-SERA4 (B) parasites measured by quantitative RT-PCR. Parasites in each parasite line were collected at 30 h
postsynchronization and subsequent 4-h intervals for 20 h. All expression levels (mRNA) were normalized to the coregulated gene MSP-1. The
peak mRNA expression level observed for SERA5 is indicated on the panels to illustrate the difference between D10 and D10S4. (C) Change
(n-fold) in gene expression levels between D10 and D10-SERA4 parasite lines. This was calculated by dividing the mean expression levels of the
individual values shown in B by those shown in A.
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SERA6 or SERA7. T. annulata possesses a gene which appears
to be orthologous to PFB0320c (immediately 5 of the SERA
locus) but which is inverted relative to Plasmodium spp. (Fig.
5). No orthology with T. annulata is discernible 3 of the SERA
locus. The orthology of flanking genes on both sides is pre-
served in rodent malaria parasites, but annotated genes are
missing due to the shortness of P. yoelii contigs. PFB0320c
codes for a protein containing a hesB domain. P. gallinaceum
appears to possess two genes orthologous to P. falciparum
SERA8, although low coverage means that information regard-
ing the locus organization is not available. It is interesting that
this species does not appear to encode a serine-type SERA,
suggesting that their function is not obligatory for Plasmodium
biology. Whether this relates to differences in avian and mam-
malian red blood cells remains to be determined. The presence
of an intact C-terminal domain in T. annulata suggests that the
lack of the domain in P. falciparum SERA8 is the result of a
gene truncation after duplication of the ancestral sequence as
opposed to a postduplication domain acquisition.
By examining the consensus tree constructed from MCMC
samples not containing the branch dividing the cysteine- and
serine-type SERA subgroups, we sought to discover whether
there was a plausible evolutionary scenario in which the cys-
teine SERA subgroup was not monophyletic. The consensus
tree constructed from these data maintained the broad group-
ing of sequences but moved the SERA6/SERA7 subtree to a
point in the tree that would require a second Ser3Cys muta-
tion to correct the original Cys3Ser mutation and would also
imply that SERA6 and SERA7 have arisen relatively recently.
Because the Cys-Ser division is supported by multiple methods
of tree reconstruction and is more parsimonious than the al-
ternative hypothesis, it is reasonable to assume monophyly of
the cysteine-type SERAs.
Various numbers of serine-type SERA genes are observed in
FIG. 5. SERA loci across the Plasmodium and Theileria genera. HMM hits for the protease and C-terminal SERA domains are indicated
schematically on the contigs on which they were found. Breaks in species tracks indicate discontinuities at contig ends. Where they exist, gene
annotations have been indicated. When HMM matches existed on multiple short contigs in a species, the contigs were ordered according to
orthology relationships with related species inferred from the phylogeny. SERA genes that have been successfully knocked out in P. falciparum are
marked in red, while those refractory to deletion are in black. Where orthology is clearly discernible from the phylogeny, it is marked by vertical
blocks that join species. Orthologies of P. gallinaceum and T. annulata genes are ambiguous due to a postspecies duplication. This ambiguity is
represented by a bifurcation in the orthology block. The phylogeny of Cys SERA genes indicates a duplication of SERA8 present only in P.
gallinaceum as well as a duplication resulting in SERA6 and SERA7 in Plasmodium spp. (excluding P. gallinaceum). Ambiguities arising from these
duplications are represented by bifurcations in the orthology blocks. Where it is clearly present, the orthology of flanking sequence is also
noted. Protease domains marked in green do not contain active-site mutations, whereas protease domains marked in blue contain the
cysteine-to-serine active-site mutation. The presence of secondary-site mutations has been marked below the corresponding protease
domain. RT-PCR expression levels (this study) and protein abundance as a percentages of SERA5 are shown above the P. falciparum (3D7)
track (16, 17). Similarly, relative copy number expression measurements for P. vivax as a percentage of P. vivax SERA4 are shown above the
P. vivax track (22). KO, knockout.
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different species, ranging from none in P. gallinaceum to nine
in P. vivax. The serine-type subgroup of the phylogeny divides
neatly into three clades: P. falciparum/P. reichenowi, P. vivax/P.
knowlesi, and P.yoelii/P.berghei/P.chabaudi (Fig. 6), and it
therefore appears that the duplications that gave rise to mul-
tiple copies of the serine-type SERAs have occurred after the
speciation events that gave rise to these clades.
The pattern of clade- and species-specific duplication among
serine-type SERAs suggests that the expansion of the serine-
type SERAs has been relatively recent and followed an ancient
cysteine-type-to-serine-type SERA split in an ancestral Plas-
modium species. The species-specific expansion of the subfam-
ily, especially in the case of P. vivax and P. falciparum, which
infect the same host, supports the hypothesis that a single
FIG. 6. SERA sequences belong to one of two major phyletic groups that separate according to their catalytic residues. Colored segments that
make up the inner disc delineate active-site and secondary-site mutations in SERA sequences. Colored segments that are part of the outer ring
mark the clade to which sequences belong. Thick lines in the phylogeny indicate branches shared by MCMC, maximum-likelihood, and
neighbor-joining topologies. Thin lines indicate branches supported by MCMC and one other method. Dashed lines indicate branches existing only
in the MCMC topology. MCMC branch probabilities are given on the appropriate branches where they are less than 1. Members of the genus
Theileria appear to have a single-copy SERA, the only observation to date of a SERA ortholog outside the genus Plasmodium. Radiation in SERA
sequences containing the serine active-site mutation tends to be species specific, whereas radiation of cysteine SERA sequences has occurred prior
to speciation. Branch lengths for SERA6 and SERA7 tend to be shorter than those of serine-type SERAs and those of SERA8.
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function for the subfamily exists and that duplication is being
driven by host selective pressure.
DISCUSSION
The function of the SERAs expressed during the erythro-
cytic cycle remains largely unknown, and the role of the serine-
type SERAs is particularly uncertain given the noncanonical
nature of their active sites. However, from the data presented
here, it now appears highly probable that the serine-type SERAs
have a crucial function(s) at this life stage. This is supported by
the notion that SERA5 appears to be refractory to genetic
deletion, while the genes encoding the rest of the members of
this group can be disrupted. While such an experiment is not
proof of essentiality, the numerous unsuccessful attempts to
delete this gene and the knowledge that the SERA locus itself
is clearly amenable to gene targeting suggest that the deletion
of SERA5 has a deleterious effect on erythrocytic-stage growth.
This is consistent with the extraordinarily high level of expres-
sion of SERA5, estimated by proteomic studies to be one of the
most abundant proteins expressed at the schizont stage. Fur-
ther evidence of a likely blood-stage function for serine-type
SERAs is the possible compensatory increase in SERA5
mRNA expression detected in the SERA4-null parasites. After
SERA5, SERA4 is the strongest-expressing member of the
SERA family, although it is present only at between 10 and
20% of the levels of SERA5. While the increase at the tran-
script level was clear, we were not able to detect an obvious
increase in SERA5 protein levels in SERA4-null parasites by
Western blotting. It is not known how much SERA5 protein is
required to compensate for the loss of SERA4 (presumably
very little); however, it is below the sensitivity of the serial
dilution Western blot technique that we employed here.
The presence of SERA5 in the parasitophorous vacuole and
demonstrated (relatively weak) in vitro catalytic activity are
suggestive of a role in schizont rupture or cleavage of invasion
ligands. However, there remains no proof of this, and indeed,
other possible roles at this stage can be envisaged, including
possible noncatalytic regulatory functions.
While an important blood-stage role for the serine-type
SERAs appears to be likely, the number of different functions
that these proteins perform appears to be far fewer than the
number of genes present. The comprehensive gene identifica-
tion and phylogenetic analysis performed in this study confirm
that the serine-type SERAs form a single monophyletic group
arising from a single ancient duplication and active-site muta-
tion of a cysteine-type SERA. This supports the notion that
redundancy is possible between the serine-type SERAs, and
indeed, it is possible that there is only one blood-stage role for
all members of this group. In addition, the ability to disrupt all
except the most strongly expressed of the serine-type SERAs
indicates that these more weakly expressed members do not
perform independent and distinct functions within the eryth-
rocytic cycle. Moreover, the apparent compensatory increase
in SERA5 expression in response to the disruption of SERA4,
already discussed above in relation to a blood-stage function, is
also consistent with functional redundancy among this group.
If all serine-type SERAs perform the same function, why is
SERA5 refractory to genetic deletion? The most likely expla-
nation for this is that the required compensatory change in the
expression of another of the serine-type SERAs is too great to
be readily achieved in culture. Formal proof of this and proof
of the hypothesis of redundant roles for the serine-type SERAs
require functional complementation experiments where the
SERA5 coding sequence is replaced with that of another
serine-type SERA. As SERA genes are large, this remains
technically challenging but is theoretically achievable.
Given that we have now seen that the serine-type SERAs
form a single monophyletic group, we propose that only one
function is likely for members of the serine-type SERAs. This
role need not be restricted to the blood stages, and indeed,
mRNA profiling suggests that some members of the serine-
type SERAs are expressed at other stages (19). With respect to
the cysteine-type SERAs, phylogenetic analysis suggests that as
many as three orthologous groups represented by P. falciparum
members SERA6, SERA7, and SERA8 (Fig. 5 and 6). Some
functional data to support this separation exist. The rodent
malaria version of the “SERA8-like” SERAs functions in oo-
cyst rupture (1), while “SERA6-like” members are most likely
to function in the erythrocytic stage, given their strong expres-
sion and apparently essential role at this stage (20).
SERAs that function in the blood stage remain attractive
drug targets, and indeed, SERA5 has even progressed consid-
erably as a vaccine candidate. There is now a strong likelihood
that interference with serine-type SERA function will interrupt
normal erythrocytic development and promote parasite clear-
ance from infected individuals. SERA5 may indeed be oblig-
atory for blood-stage growth. However, if other family mem-
bers such as SERA4 can compensate if expressed highly
enough, it is important that interventions targeting SERA5
should be designed to also block the other serine-type SERAs.
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